August 31, 2022
Any disturbance in home health reimbursements will influence the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services.
The introduction of the PDGM is a perfect example of this.
“At the time, on a national level, no one knew how 2020 reimbursement was going to shake out and, specifically, what the behavioral adjustment would ultimately be. Then there was uncertainty at the agency level, with those agencies doing heavy therapy projected to lose 10-20% of their reimbursement for the same work,” Cory Mertz, managing partner of the M&A advisory firm Mertz Taggart, told Hospice News. “This created uncertainty over a somewhat protracted period of time. So many industry consolidators paused all but the most strategic deals and pivoted to hospice.”
Click here for the full article.
About Corridor
For over 30 years, Corridor has partnered with home-based care providers, delivering powerful solutions to support the unique challenges of caring for patients in the home. Our team of operating executives, clinicians, and nationally renowned industry experts have run provider organizations and resolved the same challenges you face.
To receive the most important industry updates, insights and news impacting home health and hospice, please make sure to sign up for our weekly newsletter.
